Back to KLRA

Atlas Venture Life Science Advisors, LLC → KLRA

Atlas Venture Life Science Advisors, LLC KLRA Position History

Kailera Therapeutics, Inc. • Healthcare

Quarters held
2
Latest value
$59.1M
Q3 2026
Peak value
$113.9M
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$113.9M
Q3 2026$59.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$59.1M5.17M——
Q2 2026$113.9M5.17M——

Other funds holding KLRA

Other Atlas Venture Life Science Advisors, LLC positions

KYMR

Kymera Therapeutics, Inc.

$381.3M
KYMR

Kymera Therapeutics, Inc.

$362.6M
KYMR

Kymera Therapeutics, Inc.

$326.5M
KYMR

Kymera Therapeutics, Inc.

$318.3M
KYMR

Kymera Therapeutics, Inc.

$277.1M
DYN

Dyne Therapeutics, Inc.

$178.6M
DYN

Dyne Therapeutics, Inc.

$165.5M
DYN

Dyne Therapeutics, Inc.

$151M